Inhalation Drugs Will Have $57 “Transitional” Dispensing Fee In 2005
Executive Summary
The Centers for Medicare & Medicaid Services is increasing the dispensing fee for inhalation drugs delivered via nebulizers by over 1,000% as a means of managing the transition of the inhalation therapy market during 2005
You may also be interested in...
Inhalation Drug Dispensing Fee Likely To Decrease In 2006, CMS Says
CMS expects the dispensing fee for Part B inhalation drugs administered with a nebulizer to drop in 2006 and is soliciting comments on what the new level should be, according to its proposed Medicare FDL-1Physician Fee Schedule for 2006
Inhalation Drug Dispensing Fee Likely To Decrease In 2006, CMS Says
CMS expects the dispensing fee for Part B inhalation drugs administered with a nebulizer to drop in 2006 and is soliciting comments on what the new level should be, according to its proposed Medicare FDL-1Physician Fee Schedule for 2006
Part B Average Sales Price Drug Rates Finalized; Zoladex Down 12%
AstraZeneca's prostate cancer therapy Zoladex will be reimbursed at 12% below CMS' previously estimated rate when payment changes for Medicare Part B-covered drugs take effect Jan. 1